A review of advances in 3D and 4D bioprinting: toward mass individualization paradigm

Tariku Sinshaw Tamir (), Frehiwot Bayelign Teferi (), Xijin Hua (), Jiewu Leng (), Gang Xiong (), Zhen Shen () and Qiang Liu ()
Additional contact information
Tariku Sinshaw Tamir: Guangdong University of Technology
Frehiwot Bayelign Teferi: Menelik II Comprehensive Specialized Hospital
Xijin Hua: University of Exeter
Jiewu Leng: Guangdong University of Technology
Gang Xiong: Chinese Academy of Sciences
Zhen Shen: Chinese Academy of Sciences
Qiang Liu: Guangdong University of Technology

Journal of Intelligent Manufacturing, 2025, vol. 36, issue 8, No 2, 5217-5246

Abstract: Abstract Human tissues and organs are not permanent and may deteriorate or malfunction over time. Thus, the production of artificial tissues and organs is required. It can be achieved through 3D and 4D bioprinting methods, which combine living cells with biomaterials to generate complex living tissues and organs. These emerging manufacturing systems are reshaping the healthcare system. The presence of smart and stimuli-responsive materials ensures the desired shape and functionality of artificial organs and tissues. Most of the existing review works lack discussions of human-driven and value-oriented manufacturing schemes in bioprinting. This review article focuses on a human-interest enabled manufacturing paradigm for advancing 3D and 4D bioprinting. Involving humans in the bioprinting process establishes a human-driven system that considers value elements, ensuring reliable patient-specific products. For addressing customization, personalization, and individualization of bio-printed products, the article discusses advanced technologies like robotics, metaverses/XR, and artificial intelligence in bioprinting. The seamless interaction between humans and breakthrough technologies, combined with virtual, augmented, and mixed reality concepts, as well as the application of artificial intelligence in the bioprinting process and smart materials, enhances the bioprinting manufacturing system toward individualization. Furthermore, various application domains in tissue engineering and drug delivery systems for producing patient-specific tissues and organs are explored. Lastly, the article presents challenges and barriers in 3D/4D bioprinting, elaborating on technical and ethical considerations. It also highlights promising future trends for advancing the bioprinting industry further.

Keywords: 3D bioprinting; 4D bioprinting; Smart materials; Individualization; Patient-in-the-loop; Value-oriented manufacturing (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s10845-024-02529-6 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:joinma:v:36:y:2025:i:8:d:10.1007_s10845-024-02529-6

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/10845

DOI: 10.1007/s10845-024-02529-6

Access Statistics for this article

Journal of Intelligent Manufacturing is currently edited by Andrew Kusiak

More articles in Journal of Intelligent Manufacturing from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().